The Q is showing that CareClix is profitable (see below)
Revenue:
We recognized net revenue of $438,842 and $6,599 during the three-month periods ended June 30, 2019 and 2018, respectively. Revenues were from the sales of our nutrition supplement in the three months ended June 30, 2018 and from both supplements sales and telemedicine for the three months ended June 30, 2019. The increase in revenue is attributable to the acquisition of the CareClix™ software and start-up of the new business of CareClix, Inc. in April 2019.
Cost of Revenue:
We recognized cost of revenues of $286,012 and $2,466 during the three-month periods ended June 30, 2019 and 2018, respectively. Cost of revenue consisted of product costs and fulfillment fees for sales through the Internet for nutrition supplement sales and fees to an unrelated medical professional corporation for providing medical doctors for telemedicine consulting services.
Gross Profit / (Loss):
Gross profit was $152,830 and $4,133 for the three-month periods ended June 30, 2019 and 2018, respectively.
